Tissue Engineering
Tissue Engineering
复制标题
DOI：
10.1055/s-2003-39859
复制
发表时间：
2003
影响因子：
2
通讯作者：
Michael J. Miller;G. Bancroft;Charles Patrick, Jr.
中科院分区：
文献类型：
--
作者：
Michael J. Miller;G. Bancroft;Charles Patrick, Jr.
组织工程将潜在地改变整形外科的实践比任何其他临床专业。这是一个跨学科领域，有望实现组织修复的新方法。自1990年以来，在这一领域的投资已超过35亿美元。相关领域的进展包括先进的计算，生物材料，细胞技术，生长因子的制造和交付，基因操纵。有益的临床技术将从这些领域的持续研究中出现。所开发的技术必须通过监管机构批准的产品扩大到行业，并为临床医生和患者所接受。组织工程的目标是改变临床实践，改善患者的治疗效果，降低护理成本。
Tissue engineering will potentially change the practice of plastic surgery more than any other clinical specialty. It is an interdisciplinary field that promises new methods of tissue repair. There has been more than $3.5 billion invested in this field since 1990. Relevant areas of progress include advanced computing, biomaterials, cell technology, growth factor fabrication and delivery, and gene manipulation. Beneficial clinical techniques will emerge from continued investigation in each of these areas. Techniques that are developed must be scaled up to industry with products cleared by regulatory agencies and acceptable to clinicians and patients. A goal of tissue engineering is to change clinical practice, yielding improved patient outcomes and lower costs of care.